FDA expands authorization for Pfizer COVID-19 booster to include Americans aged 16 or 17

The Food and Drug Administration (FDA) has expanded the availability of the COVID-19 vaccine booster shots in the wake of new data showing the Omicron variant can bypass protection provided by the first two doses.

from Health News | Mail Online https://ift.tt/3pFUqVm